Gene_set	Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Z-score	Combined Score	Genes
KEGG_2019_Human	Glyoxylate and dicarboxylate metabolism	2/30	0.19268422474893213	0.8408038898135219	0.22862160433066042	0.9967043287141466	-715.9143337951358	1178.8979742303081	GCSH;GLDC
KEGG_2019_Human	Ribosome biogenesis in eukaryotes	23/101	2.203019145676184e-15	4.2297967596982716e-13	3.952011477824684e-13	7.58786203742339e-11	-34.656711902572944	1169.6275552497054	NOP58;UTP6;WDR36;CSNK2A1;UTP4;POP1;WDR3;HEATR1;RPP40;WDR75;NAT10;IMP4;UTP18;NOL6;FBL;NXF1;LSG1;TBL3;XPO1;NXF2B;MPHOSPH10;RIOK1;MDN1
KEGG_2019_Human	Glycine, serine and threonine metabolism	3/40	0.09209448875261715	0.5923042879974711	0.12095974865116853	0.8139255297457741	-286.27861219177663	682.7573641267068	GCSH;CBS;GLDC
KEGG_2019_Human	mRNA surveillance pathway	15/91	1.923280369690838e-08	9.231745774516023e-07	2.4537159582414124e-07	1.1777836599558783e-05	-25.248009555243577	448.57251083770143	UPF2;UPF1;SMG1;RNGTT;CPSF1;RNMT;CPSF3;EIF4A3;CPSF2;CASC3;PNN;NXF1;CSTF1;NXF2B;SYMPK
KEGG_2019_Human	Basal transcription factors	5/45	0.006959856865065985	0.13362925180926694	0.013020299279171803	0.2695153684927622	-62.99244861776384	312.9210591043293	TAF6L;GTF2IRD1;GTF2E2;TAF2;GTF2I
KEGG_2019_Human	Cytosolic DNA-sensing pathway	6/63	0.006848331198383628	0.13362925180926694	0.013010162596375316	0.2695153684927622	-52.335091460039976	260.8250265640532	POLR3A;POLR3B;POLR3C;POLR3E;POLR3F;CASP1
KEGG_2019_Human	RNA polymerase	6/31	0.00015298252632097538	0.005874529010725452	0.0005331064078431194	0.019958511064558954	-27.70464755399975	243.39050537933946	POLR3A;POLR3B;POLR3C;POLR2B;POLR3E;POLR3F
KEGG_2019_Human	Amyotrophic lateral sclerosis (ALS)	3/51	0.15747497241763703	0.7851578144171626	0.1957020164706064	0.9686442751868571	-129.90789082704944	240.1332732527264	CASP1;TP53;BCL2L1
KEGG_2019_Human	Spliceosome	22/134	1.0170007385651471e-11	9.763207090225416e-10	3.6274191878695804e-10	3.232560504410431e-08	-8.409206259753292	212.85028167253856	SF3B4;TCERG1;AQR;RBM25;SF3B2;EIF4A3;DDX23;PRPF40A;USP39;WBP11;PRPF19;PRPF8;U2SURP;CHERP;SART1;PRPF6;PUF60;ZMAT2;PRPF3;PPIE;DHX16;SNRNP200
KEGG_2019_Human	Thyroid hormone signaling pathway	8/116	0.01314842768716645	0.2103748429946632	0.024043588964520322	0.3846974234323252	-40.85866663353474	176.97739804833657	MED12;MED1;MED14;MED24;STAT1;EP300;TP53;MED17
KEGG_2019_Human	Lysine degradation	4/59	0.07411887276484548	0.5759086051261446	0.10212826286461696	0.789627163391874	-63.31486134149452	164.75065641418178	SETDB1;EHMT2;KMT2B;COLGALT1
KEGG_2019_Human	Endometrial cancer	2/58	0.46487735084581905	0.9917748408397812	0.5095184890870441	0.9967043287141466	-201.50435158191812	154.3486396982737	ERBB2;TP53
KEGG_2019_Human	RNA transport	24/165	1.679691132956236e-11	1.075002325091991e-09	5.050875788141299e-10	3.232560504410431e-08	-5.521671037088749	136.99169818867753	UPF2;UPF1;POP1;GEMIN2;EIF4A3;RPP40;NUP153;CASC3;RANGAP1;SENP2;FXR1;PNN;NXF1;XPO1;EIF5;SUMO1;SUMO3;NUP50;XPO5;TACC3;NXF2B;GEMIN5;RAE1;EIF4B
KEGG_2019_Human	Salmonella infection	4/86	0.2011271733016863	0.8533298753333148	0.24994937331438813	0.9967043287141466	-82.5741793247992	132.43394423669366	KLC3;CASP1;WASF1;RAB7A
KEGG_2019_Human	Necroptosis	9/162	0.031407842468201046	0.3673308671132625	0.05320423877553714	0.603133971682974	-31.07517766106361	107.54179452619977	PARP1;STAT1;STAT2;STAT3;TNFSF10;CASP1;EIF2AK2;SQSTM1;CHMP5
KEGG_2019_Human	Homologous recombination	3/41	0.09747756461209657	0.5923042879974711	0.12725310919852906	0.8139255297457741	-45.550086538247726	106.0466611712308	NBN;TOPBP1;RAD54B
KEGG_2019_Human	Malaria	5/49	0.009954390091030512	0.17374935431616884	0.01775395348861036	0.3098871881648355	-19.79924496060648	91.26940334029236	COMP;CD40;VCAM1;THBS2;ICAM1
KEGG_2019_Human	NF-kappa B signaling pathway	6/95	0.04308801682196117	0.4267030441391696	0.06602963927837935	0.6366782322338177	-28.216030376604337	88.72559962578696	CD40;VCAM1;PARP1;CSNK2A1;BCL2L1;ICAM1
KEGG_2019_Human	Bladder cancer	3/41	0.09747756461209657	0.5923042879974711	0.12725310919852906	0.8139255297457741	-35.308215101644684	82.20222194969926	CDKN2A;ERBB2;TP53
KEGG_2019_Human	Fatty acid elongation	2/27	0.1635745446702421	0.7851578144171626	0.19727123306362954	0.9686442751868571	-43.094985273347405	78.02288741079678	ACOT7;THEM4
KEGG_2019_Human	Ubiquitin mediated proteolysis	10/137	0.003975909650986015	0.10905352185561641	0.00868201742708912	0.23813533514301563	-13.30005074660465	73.5160532986903	UBE2C;UBE2S;FBXO2;UBR5;HUWE1;KEAP1;UBE2J2;SAE1;PRPF19;PIAS2
KEGG_2019_Human	Small cell lung cancer	4/93	0.24104406298827505	0.9042021120241135	0.2940500694071797	0.9967043287141466	-50.4508318074403	71.78020887433907	CCNE1;TP53;BCL2L1;CKS1B
KEGG_2019_Human	Alanine, aspartate and glutamate metabolism	2/35	0.24238576200589174	0.9042021120241135	0.28142349598101507	0.9967043287141466	-50.37216584696078	71.38868086024709	CAD;NAT8L
KEGG_2019_Human	Pancreatic cancer	6/75	0.015526984376881098	0.2293216154123976	0.026700252968476435	0.3943421976882676	-17.101150002602985	71.22929684713544	STAT1;CDKN2A;STAT3;ERBB2;TP53;BCL2L1
KEGG_2019_Human	African trypanosomiasis	2/37	0.2624544368478351	0.9042021120241135	0.30251934957687715	0.9967043287141466	-52.0508484155128	69.62726366419761	VCAM1;ICAM1
KEGG_2019_Human	Biosynthesis of unsaturated fatty acids	2/27	0.1635745446702421	0.7851578144171626	0.19727123306362954	0.9686442751868571	-34.67623694186773	62.780857530974274	ACOT7;FADS1
KEGG_2019_Human	DNA replication	2/36	0.2524153052586109	0.9042021120241135	0.29198140338108036	0.9967043287141466	-38.524047611706465	53.035267037553986	RFC4;MCM3
KEGG_2019_Human	Base excision repair	2/33	0.22238862077297264	0.9042021120241135	0.26027916886164315	0.9967043287141466	-34.9058839712734	52.4750235782499	PARP1;UNG
KEGG_2019_Human	Adherens junction	5/72	0.04444823376449682	0.4267030441391696	0.06632064919102271	0.6366782322338177	-15.542371467525653	48.390086424115935	CSNK2A1;ERBB2;EP300;WASF1;NECTIN3
KEGG_2019_Human	Endocrine and other factor-regulated calcium reabsorption	1/48	0.7303002862732675	0.9917748408397812	0.755757318948389	0.9967043287141466	-141.60574686901174	44.506612374003545	DNM2
KEGG_2019_Human	Mismatch repair	3/23	0.022980524628827277	0.31516148062391686	0.03592533496976794	0.4926903081568176	-11.720026853132525	44.22092915446132	MSH6;RFC4;MSH2
KEGG_2019_Human	Mitophagy	5/65	0.03049099997956222	0.3673308671132625	0.047458724359748204	0.603133971682974	-11.861685097621546	41.401120873802654	CSNK2A1;SQSTM1;TP53;BCL2L1;RAB7A
KEGG_2019_Human	Toxoplasmosis	5/113	0.1887169868410134	0.8408038898135219	0.2412925161881085	0.9967043287141466	-24.681490221870288	41.1565530334225	CD40;STAT1;ALOX5;STAT3;BCL2L1
KEGG_2019_Human	Cysteine and methionine metabolism	2/47	0.3618563030598736	0.9917748408397812	0.4053947523827506	0.9967043287141466	-40.33444318923928	41.000288163914014	CBS;DNMT3A
KEGG_2019_Human	Thyroid cancer	3/37	0.07673050269849628	0.5759086051261446	0.1028160368999836	0.789627163391874	-15.795138213872715	40.55332176659506	PAX8;CCDC6;TP53
KEGG_2019_Human	Protein processing in endoplasmic reticulum	8/165	0.0779876236108321	0.5759086051261446	0.11690025846718444	0.8139255297457741	-12.152947340232144	31.00466167847878	GANAB;NPLOC4;OS9;FBXO2;EIF2AK2;UBE2J2;HSPBP1;PDIA6
KEGG_2019_Human	Basal cell carcinoma	2/63	0.5083879236373392	0.9917748408397812	0.5527822491347116	0.9967043287141466	-45.759244102789424	30.95660881532353	WNT7A;TP53
KEGG_2019_Human	Pathogenic Escherichia coli infection	4/55	0.060280092616765014	0.5260808082917672	0.08494092401353764	0.7413026095726923	-10.808479884655876	30.358354287443337	TUBB2B;NCL;ARHGEF2;TUBB4A
KEGG_2019_Human	Asthma	1/31	0.5708568011920531	0.9917748408397812	0.6013048544919488	0.9967043287141466	-52.80998740396076	29.606170729384257	CD40
KEGG_2019_Human	Fc gamma R-mediated phagocytosis	5/91	0.09875393960389581	0.5923042879974711	0.1352316089455855	0.8139255297457741	-12.342245914323714	28.57382949902797	HCK;WASF1;DOCK2;VAV1;DNM2
KEGG_2019_Human	One carbon pool by folate	2/20	0.09983498414525191	0.5923042879974711	0.12714917062792097	0.8139255297457741	-12.280971945863971	28.298265219955574	MTHFD2;GART
KEGG_2019_Human	Chronic myeloid leukemia	3/76	0.33549673597618695	0.9917748408397812	0.38742123422715774	0.9967043287141466	-25.51318304769305	27.8640455859544	CDKN2A;TP53;BCL2L1
KEGG_2019_Human	Non-small cell lung cancer	4/66	0.10180229949956542	0.5923042879974711	0.13565425495762903	0.8139255297457741	-11.533893289574502	26.351746511468207	CDKN2A;STAT3;ERBB2;TP53
KEGG_2019_Human	Other types of O-glycan biosynthesis	2/22	0.11726139094790224	0.6621819724116839	0.14656574270658643	0.8276653705783703	-12.29330336174039	26.348848385050808	POFUT1;COLGALT1
KEGG_2019_Human	Colorectal cancer	3/86	0.40880120325730557	0.9917748408397812	0.46294546077787735	0.9967043287141466	-28.62567843999015	25.60642212568591	MSH6;MSH2;TP53
KEGG_2019_Human	Citrate cycle (TCA cycle)	1/30	0.5589754178560479	0.9917748408397812	0.589658502918276	0.9967043287141466	-43.617724964032995	25.37024021696104	PCK1
KEGG_2019_Human	Measles	8/138	0.03320183106404887	0.3673308671132625	0.054736640035488886	0.603133971682974	-6.7552284493648695	23.002567857003	CSNK2A1;STAT1;CCNE1;STAT2;STAT3;EIF2AK2;TP53;BCL2L1
KEGG_2019_Human	Hepatocellular carcinoma	14/168	0.00018639323362330573	0.0059645834759457835	0.0006237034707674673	0.019958511064558954	-2.4303921377264976	20.87136179703646	SMARCE1;SMARCD1;SMARCC1;SMARCB1;PHF10;CDKN2A;ACTL6A;WNT7A;KEAP1;ARID1A;SMARCA4;BRD7;TP53;BCL2L1
KEGG_2019_Human	Cholesterol metabolism	2/50	0.39081763866096025	0.9917748408397812	0.43491010865963203	0.9967043287141466	-21.52433484264501	20.222418770057864	STARD3;NCEH1
KEGG_2019_Human	Inflammatory bowel disease (IBD)	2/65	0.5251342779180511	0.9917748408397812	0.5693216236703156	0.9967043287141466	-30.825120895446034	19.854499875171282	STAT1;STAT3
KEGG_2019_Human	Intestinal immune network for IgA production	1/48	0.7303002862732675	0.9917748408397812	0.755757318948389	0.9967043287141466	-58.38264484808128	18.34963482115069	CD40
KEGG_2019_Human	TGF-beta signaling pathway	3/90	0.4374928009545574	0.9917748408397812	0.4920479570887058	0.9967043287141466	-19.850139898675774	16.410011964914872	ID4;EP300;INHBA
KEGG_2019_Human	Renal cell carcinoma	2/69	0.5574543036433286	0.9917748408397812	0.6010644251003552	0.9967043287141466	-26.468332238909387	15.467424917678482	EP300;PAK2
KEGG_2019_Human	Pyruvate metabolism	2/39	0.2825308404540209	0.9042021120241135	0.3235066453055791	0.9967043287141466	-11.875683734069176	15.010479047376306	ME2;PCK1
KEGG_2019_Human	Allograft rejection	1/38	0.6455447368455017	0.9917748408397812	0.6741144749347243	0.9967043287141466	-30.94344496947212	13.542731808583927	CD40
KEGG_2019_Human	Influenza A	11/171	0.006690705152826356	0.13362925180926694	0.014037258775664687	0.2695153684927622	-2.631913857923613	13.178087452331646	NXF1;XPO1;STAT1;STAT2;TNFSF10;CASP1;NXF2B;EP300;EIF2AK2;RAE1;ICAM1
KEGG_2019_Human	Central carbon metabolism in cancer	2/65	0.5251342779180511	0.9917748408397812	0.5693216236703156	0.9967043287141466	-20.393682199902443	13.135596842121872	ERBB2;TP53
KEGG_2019_Human	Ferroptosis	1/40	0.6643937322432503	0.9917748408397812	0.6923697100468571	0.9967043287141466	-30.15929591536344	12.331543017154475	TP53
KEGG_2019_Human	Legionellosis	1/55	0.777275527307433	0.9917748408397812	0.8004478891396458	0.9967043287141466	-48.8722789282348	12.313878335415193	CASP1
KEGG_2019_Human	p53 signaling pathway	4/72	0.12875582427133717	0.6926780429056618	0.16745945261484527	0.9186347114871503	-5.609760615913562	11.499097695610075	CDKN2A;CCNE1;TP53;BCL2L1
KEGG_2019_Human	Pyrimidine metabolism	2/57	0.45590469592512206	0.9917748408397812	0.5005445862330834	0.9967043287141466	-14.579052076905345	11.451429779146332	CAD;TK1
KEGG_2019_Human	Primary immunodeficiency	2/37	0.2624544368478351	0.9042021120241135	0.30251934957687715	0.9967043287141466	-8.524333648256817	11.402811761121635	CD40;UNG
KEGG_2019_Human	Autoimmune thyroid disease	1/53	0.7647566267732896	0.9917748408397812	0.7885829147065487	0.9967043287141466	-40.024620616652655	10.734508419378097	CD40
KEGG_2019_Human	Arachidonic acid metabolism	1/63	0.8210441272645232	0.9917748408397812	0.841635647260578	0.9967043287141466	-53.84923123052317	10.617906482135396	ALOX5
KEGG_2019_Human	Notch signaling pathway	2/48	0.3715711898968556	0.9917748408397812	0.4153173012643666	0.9967043287141466	-10.637007814276274	10.53079521626132	EP300;CIR1
KEGG_2019_Human	Viral myocarditis	2/59	0.4737620232663252	0.9917748408397812	0.5183868247080465	0.9967043287141466	-14.03961986235874	10.488300039617254	CD40;ICAM1
KEGG_2019_Human	Fluid shear stress and atherosclerosis	8/139	0.03443726879186832	0.3673308671132625	0.05654380984527881	0.603133971682974	-3.0260729472736645	10.193677462718638	VCAM1;SUMO1;SUMO3;KEAP1;ARHGEF2;SQSTM1;TP53;ICAM1
KEGG_2019_Human	Cell cycle	7/124	0.0503350788240669	0.46020643496289715	0.0775597955207098	0.7091181304750609	-3.303974995093361	9.875756545500856	ORC5;CDKN2A;CCNE1;ORC3;MCM3;EP300;TP53
KEGG_2019_Human	Wnt signaling pathway	8/158	0.06402531349768888	0.5344721822415766	0.09812187182357848	0.789627163391874	-2.9827356913863308	8.197979700422772	SFRP2;CSNK2A1;TBL1XR1;CHD8;WNT7A;EP300;SENP2;TP53
KEGG_2019_Human	Signaling pathways regulating pluripotency of stem cells	6/139	0.17236912984582609	0.8025067256915894	0.22714218602216657	0.9967043287141466	-4.408254214720689	7.750226666427733	RIF1;SETDB1;STAT3;ID4;WNT7A;INHBA
KEGG_2019_Human	Prostate cancer	4/97	0.26461486909709675	0.9042021120241135	0.31970467997350926	0.9967043287141466	-5.569726021935054	7.4048384285030355	CCNE1;ERBB2;EP300;TP53
KEGG_2019_Human	Ether lipid metabolism	1/47	0.7228267634492672	0.9917748408397812	0.7486070624892628	0.9967043287141466	-19.792812019869988	6.424463615545765	PLD3
KEGG_2019_Human	Peroxisome	3/83	0.3869954158219304	0.9917748408397812	0.44065802947206273	0.9967043287141466	-6.663965546858019	6.326385255312442	NUDT19;ABCD1;PEX14
KEGG_2019_Human	Proximal tubule bicarbonate reclamation	1/23	0.4660877516022095	0.9917748408397812	0.4980823249814804	0.9967043287141466	-8.245969038269285	6.294819012980617	PCK1
KEGG_2019_Human	Melanoma	2/72	0.5806489733273602	0.9917748408397812	0.6236984832995599	0.9967043287141466	-10.48865618906448	5.701726658700282	CDKN2A;TP53
KEGG_2019_Human	Acute myeloid leukemia	1/66	0.8351447641213329	0.9917748408397812	0.8547950350998046	0.9967043287141466	-30.958287979598428	5.577141738767978	STAT3
KEGG_2019_Human	Th17 cell differentiation	3/107	0.5523299600419587	0.9917748408397812	0.6060603849418785	0.9967043287141466	-9.180242653652707	5.449480698222587	STAT1;IRF4;STAT3
KEGG_2019_Human	Fanconi anemia pathway	1/54	0.771101487385834	0.9917748408397812	0.7946006800140946	0.9967043287141466	-18.641087019311907	4.84547623409407	TELO2
KEGG_2019_Human	Nicotinate and nicotinamide metabolism	1/30	0.5589754178560479	0.9917748408397812	0.589658502918276	0.9967043287141466	-7.705141959026629	4.481694140799054	CD38
KEGG_2019_Human	Cortisol synthesis and secretion	1/65	0.8305722984959379	0.9917748408397812	0.8505342379146886	0.9967043287141466	-22.209759860452586	4.1230264731714	NCEH1
KEGG_2019_Human	AGE-RAGE signaling pathway in diabetic complications	4/100	0.28256316000753534	0.9042021120241135	0.3390624511667495	0.9967043287141466	-2.968204930445701	3.751375234705562	VCAM1;STAT1;STAT3;ICAM1
KEGG_2019_Human	Aminoacyl-tRNA biosynthesis	1/66	0.8351447641213329	0.9917748408397812	0.8547950350998046	0.9967043287141466	-20.60125319064104	3.7113198609744806	SARS2
KEGG_2019_Human	Longevity regulating pathway	4/102	0.2946297337146136	0.9273591618558333	0.35199434627248655	0.9967043287141466	-2.460396515244168	3.0066927491578266	RB1CC1;EHMT2;TP53;ATG13
KEGG_2019_Human	Nucleotide excision repair	1/47	0.7228267634492672	0.9917748408397812	0.7486070624892628	0.9967043287141466	-7.6979152546914875	2.4986331613553627	RFC4
KEGG_2019_Human	Shigellosis	1/65	0.8305722984959379	0.9917748408397812	0.8505342379146886	0.9967043287141466	-13.110858695699918	2.4339037354759894	WASF1
KEGG_2019_Human	ECM-receptor interaction	2/82	0.6514293955914082	0.9917748408397812	0.6919828100303199	0.9967043287141466	-5.57492769684365	2.3893374134098058	COMP;THBS2
KEGG_2019_Human	Adipocytokine signaling pathway	2/69	0.5574543036433286	0.9917748408397812	0.6010644251003552	0.9967043287141466	-3.9747457794668937	2.322741053566918	STAT3;PCK1
KEGG_2019_Human	Ovarian steroidogenesis	1/49	0.7375726622872434	0.9917748408397812	0.7627050744144142	0.9967043287141466	-7.370345370220687	2.2434643689563267	ALOX5
KEGG_2019_Human	Cell adhesion molecules (CAMs)	5/145	0.35136131823442046	0.9917748408397812	0.4191658499943044	0.9967043287141466	-1.9936192069943184	2.0852064487670185	CD40;VCAM1;L1CAM;NECTIN3;ICAM1
KEGG_2019_Human	Bacterial invasion of epithelial cells	2/74	0.5956092394463743	0.9917748408397812	0.6382310946652847	0.9967043287141466	-4.0174751754814455	2.0817369816311317	WASF1;DNM2
KEGG_2019_Human	N-Glycan biosynthesis	1/50	0.7446492954089761	0.9917748408397812	0.7694560392036269	0.9967043287141466	-6.875567367786096	2.0272054553081555	GANAB
KEGG_2019_Human	Prolactin signaling pathway	2/70	0.5652861339211126	0.9917748408397812	0.6087207667060767	0.9967043287141466	-3.5137714113611187	2.0043368882329577	STAT1;STAT3
KEGG_2019_Human	ABC transporters	1/45	0.7072539127230768	0.9917748408397812	0.733675375810673	0.9967043287141466	-5.605780374946033	1.9416491271267935	ABCD1
KEGG_2019_Human	B cell receptor signaling pathway	2/71	0.5730177861217202	0.9917748408397812	0.616265396570618	0.9967043287141466	-3.3202837196538963	1.8488618803912111	PIK3AP1;VAV1
KEGG_2019_Human	ErbB signaling pathway	2/85	0.6707229552815805	0.9917748408397812	0.7103809691091488	0.9967043287141466	-3.510853969022511	1.4022319526958178	ERBB2;PAK2
KEGG_2019_Human	Fc epsilon RI signaling pathway	2/68	0.5495226746108034	0.9917748408397812	0.5932962873443498	0.9967043287141466	-2.210865538552361	1.3236567870936842	ALOX5;VAV1
KEGG_2019_Human	C-type lectin receptor signaling pathway	3/104	0.5330557657396161	0.9917748408397812	0.5871987523848083	0.9967043287141466	-2.080879276841856	1.3091419857692	STAT1;STAT2;CASP1
KEGG_2019_Human	GABAergic synapse	2/89	0.6950918226786018	0.9917748408397812	0.733479111700624	0.9967043287141466	-3.487010327368936	1.268265140117594	SLC38A1;SLC38A2
KEGG_2019_Human	Glioma	2/75	0.6029381654734065	0.9917748408397812	0.6453313357316129	0.9967043287141466	-2.4127959080136683	1.2207314873915192	CDKN2A;TP53
KEGG_2019_Human	Gap junction	2/88	0.6891429378840153	0.9917748408397812	0.7278551714269551	0.9967043287141466	-3.136873042702213	1.1678784507979918	TUBB2B;TUBB4A
KEGG_2019_Human	VEGF signaling pathway	1/59	0.800353464543504	0.9917748408397812	0.8222254206113803	0.9967043287141466	-4.837595996250807	1.0773414241462569	MAPKAPK3
KEGG_2019_Human	JAK-STAT signaling pathway	7/162	0.14759813552201465	0.7659146491953189	0.20180089066392867	0.9686442751868571	-0.4969334805221583	0.9507639442443904	STAT1;STAT2;STAT3;EP300;PIAS2;PTPN2;BCL2L1
KEGG_2019_Human	Drug metabolism	3/108	0.5586491318336594	0.9917748408397812	0.6122200728019351	0.9967043287141466	-1.1071986377402503	0.6446483307362695	IMPDH2;GMPS;TK1
KEGG_2019_Human	HIF-1 signaling pathway	3/100	0.5066477662623536	0.9917748408397812	0.5611762612909253	0.9967043287141466	-0.7895923180894415	0.5368748148331325	STAT3;ERBB2;EP300
KEGG_2019_Human	Leukocyte transendothelial migration	3/112	0.5833804770502402	0.9917748408397812	0.6362113446106367	0.9967043287141466	-0.4718740735912706	0.2543003401684181	VCAM1;VAV1;ICAM1
KEGG_2019_Human	Rheumatoid arthritis	1/91	0.9168496005685834	0.9917748408397812	0.9296192558684523	0.9967043287141466	-0.3072679454970197	0.026674493461135103	ICAM1
KEGG_2019_Human	Th1 and Th2 cell differentiation	1/92	0.9190965700373573	0.9917748408397812	0.9316321611239149	0.9967043287141466	-0.2565178895211521	0.02164089588023772	STAT1
KEGG_2019_Human	Protein digestion and absorption	1/90	0.9145403442000462	0.9917748408397812	0.9275473548408979	0.9967043287141466	0.2735010775100717	-0.024432862112650288	SLC38A2
KEGG_2019_Human	Salivary secretion	1/90	0.9145403442000462	0.9917748408397812	0.9275473548408979	0.9967043287141466	0.5781340662795983	-0.051646852921502936	CD38
KEGG_2019_Human	Leishmaniasis	1/74	0.8675574320969638	0.9917748408397812	0.8848028394537596	0.9967043287141466	1.0395330365699575	-0.1476901646550843	STAT1
KEGG_2019_Human	Pertussis	1/76	0.8746129288986751	0.9917748408397812	0.8912846617574268	0.9967043287141466	1.1123492427862909	-0.14902571891057995	CASP1
KEGG_2019_Human	RNA degradation	1/79	0.8844989402535145	0.9917748408397812	0.9003327774196753	0.9967043287141466	1.6022001296042283	-0.19664437224829967	DHX36
KEGG_2019_Human	Glycolysis / Gluconeogenesis	1/68	0.8439234761959455	0.9917748408397812	0.8629572216461245	0.9967043287141466	1.4630770390486336	-0.2482745998981229	PCK1
KEGG_2019_Human	AMPK signaling pathway	1/120	0.9624514328870292	0.9917748408397812	0.9697071507450871	0.9967043287141466	6.890831541032819	-0.2637236544096418	PCK1
KEGG_2019_Human	Parkinson disease	2/142	0.8983090386767554	0.9917748408397812	0.9184088062179742	0.9967043287141466	2.4714139269998654	-0.2650372193066646	UCHL1;UBE2J2
KEGG_2019_Human	Glutamatergic synapse	2/114	0.8154205429412499	0.9917748408397812	0.8449310201800281	0.9967043287141466	1.3079461313354186	-0.2668881021723523	SLC38A1;SLC38A2
KEGG_2019_Human	Glycerophospholipid metabolism	1/97	0.9294542560951139	0.9917748408397812	0.9408686677334477	0.9967043287141466	3.875498872479784	-0.2835225314858733	PLD3
KEGG_2019_Human	Long-term potentiation	1/67	0.8395940526407333	0.9917748408397812	0.8589348902806968	0.9967043287141466	1.88989555024996	-0.3304232423809632	EP300
KEGG_2019_Human	Axon guidance	2/181	0.9574955974295711	0.9917748408397812	0.968107471675434	0.9967043287141466	7.8851338915416775	-0.3424841349164933	L1CAM;PAK2
KEGG_2019_Human	Glucagon signaling pathway	2/103	0.7688463621485726	0.9917748408397812	0.8023533690748698	0.9967043287141466	1.369523758100084	-0.3599986555481715	EP300;PCK1
KEGG_2019_Human	Hematopoietic cell lineage	1/97	0.9294542560951139	0.9917748408397812	0.9408686677334477	0.9967043287141466	5.196195594252731	-0.3801416481991149	CD38
KEGG_2019_Human	PPAR signaling pathway	1/74	0.8675574320969638	0.9917748408397812	0.8848028394537596	0.9967043287141466	2.7452637593793368	-0.3900294097263012	PCK1
KEGG_2019_Human	Apoptosis	4/143	0.5389664541779118	0.9917748408397812	0.6015032590030405	0.9967043287141466	0.6496348277147104	-0.401540551951259	PARP1;TNFSF10;TP53;BCL2L1
KEGG_2019_Human	Calcium signaling pathway	2/188	0.963801837271697	0.9917748408397812	0.9731739605194972	0.9967043287141466	10.938432923850401	-0.4032953019546144	ERBB2;CD38
KEGG_2019_Human	Bile secretion	1/72	0.8601057036636189	0.9917748408397812	0.8779363612729278	0.9967043287141466	2.8208968453935777	-0.4251091152515141	NCEH1
KEGG_2019_Human	Melanogenesis	2/101	0.7593530926999197	0.9917748408397812	0.7935820776661211	0.9967043287141466	1.5503308325566083	-0.4267880974484977	WNT7A;EP300
KEGG_2019_Human	Insulin resistance	2/108	0.7911643131933853	0.9917748408397812	0.8228540210788988	0.9967043287141466	1.852774411384276	-0.4340116728173184	STAT3;PCK1
KEGG_2019_Human	Hippo signaling pathway	2/160	0.9316616526490032	0.9917748408397812	0.9468162002750417	0.9967043287141466	6.4130641706560985	-0.4539523633108489	PRKCI;WNT7A
KEGG_2019_Human	FoxO signaling pathway	4/132	0.47627182521921707	0.9917748408397812	0.5395831678422253	0.9967043287141466	0.6249717115796317	-0.4635830955712563	STAT3;TNFSF10;EP300;PCK1
KEGG_2019_Human	Amoebiasis	1/96	0.9274944496816733	0.9917748408397812	0.939126576557275	0.9967043287141466	6.585999882226279	-0.4957181259221239	RAB7A
KEGG_2019_Human	Hepatitis B	6/163	0.27562700848982	0.9042021120241135	0.3441082403837706	0.9967043287141466	0.41296595925448	-0.5321920174644958	STAT1;CCNE1;STAT2;STAT3;EP300;TP53
KEGG_2019_Human	Thyroid hormone synthesis	1/74	0.8675574320969638	0.9917748408397812	0.8848028394537596	0.9967043287141466	3.8713697885428564	-0.5500193080897197	PAX8
KEGG_2019_Human	Kaposi sarcoma-associated herpesvirus infection	8/186	0.12987713304481147	0.6926780429056618	0.18360915907321232	0.9686442751868571	0.2807422599906383	-0.5730416698004799	HCK;STAT1;STAT2;STAT3;EP300;EIF2AK2;TP53;ICAM1
KEGG_2019_Human	Insulin signaling pathway	2/137	0.8866435999461114	0.9917748408397812	0.9082871518217545	0.9967043287141466	4.810962626901667	-0.5788174078495414	PRKCI;PCK1
KEGG_2019_Human	Huntington disease	3/193	0.8949682699233965	0.9917748408397812	0.9197377294066152	0.9967043287141466	5.746088307660643	-0.6376262613096231	POLR2B;EP300;TP53
KEGG_2019_Human	Vascular smooth muscle contraction	1/132	0.972986974029517	0.9917748408397812	0.9786476267865769	0.9967043287141466	24.252102459049002	-0.6641337446511504	ARHGEF1
KEGG_2019_Human	Choline metabolism in cancer	1/99	0.9332166611585341	0.9917748408397812	0.9442053318501008	0.9967043287141466	9.760909373997961	-0.6746534135831237	WASF1
KEGG_2019_Human	Serotonergic synapse	1/113	0.954503146134214	0.9917748408397812	0.9628604209680767	0.9967043287141466	15.173462155582893	-0.7065422464604086	ALOX5
KEGG_2019_Human	Oxytocin signaling pathway	1/153	0.9848268012666526	0.9917748408397812	0.9884370879542425	0.9967043287141466	46.326897018699405	-0.7083146077850286	CD38
KEGG_2019_Human	Sphingolipid signaling pathway	1/119	0.9614070690857613	0.9917748408397812	0.968812009271607	0.9967043287141466	18.0207252645972	-0.7092483634637733	TP53
KEGG_2019_Human	Autophagy	4/128	0.45266758337473656	0.9917748408397812	0.5159065107534495	0.9967043287141466	0.9088506231309224	-0.7203524903811678	RB1CC1;ATG13;BCL2L1;RAB7A
KEGG_2019_Human	Neurotrophin signaling pathway	2/119	0.8336777155601789	0.9917748408397812	0.8613950326991576	0.9967043287141466	4.220929082586808	-0.7678223862375522	MAGED1;TP53
KEGG_2019_Human	Rap1 signaling pathway	1/206	0.9964708029603064	0.9964708029603064	0.9975590482411364	0.9975590482411364	229.26267223723084	-0.8105442721758075	PRKCI
KEGG_2019_Human	Epstein-Barr virus infection	9/201	0.09396640390314732	0.5923042879974711	0.14053031433171453	0.8176309197481576	0.38542317420090016	-0.9114556468176688	CD40;STAT1;CCNE1;STAT2;STAT3;EIF2AK2;CIR1;TP53;ICAM1
KEGG_2019_Human	Synaptic vesicle cycle	1/78	0.8812932257648769	0.9917748408397812	0.8974032863557009	0.9967043287141466	7.7550640109885025	-0.979967698594088	DNM2
KEGG_2019_Human	Parathyroid hormone synthesis, secretion and action	1/106	0.9448761410915044	0.9917748408397812	0.9544745282804769	0.9967043287141466	17.628429921551028	-0.9995571447767024	ARHGEF1
KEGG_2019_Human	mTOR signaling pathway	3/152	0.7797079769445415	0.9917748408397812	0.8195726284945204	0.9967043287141466	4.378589490790656	-1.0895498973294528	WNT7A;EIF4B;TELO2
KEGG_2019_Human	Progesterone-mediated oocyte maturation	1/99	0.9332166611585341	0.9917748408397812	0.9442053318501008	0.9967043287141466	16.450349029994644	-1.137013335794755	STK10
KEGG_2019_Human	Hepatitis C	5/155	0.40478916108744745	0.9917748408397812	0.4747464372513982	0.9967043287141466	1.4244377101657284	-1.2882457069996878	STAT1;STAT2;STAT3;EIF2AK2;TP53
KEGG_2019_Human	Gastric cancer	4/149	0.5715189619652594	0.9917748408397812	0.633099959250414	0.9967043287141466	2.3971135007643007	-1.3410834068302675	CCNE1;ERBB2;WNT7A;TP53
KEGG_2019_Human	Breast cancer	3/147	0.7601819115660168	0.9917748408397812	0.801962686959735	0.9967043287141466	5.011605756027675	-1.3741698545831635	ERBB2;WNT7A;TP53
KEGG_2019_Human	cGMP-PKG signaling pathway	2/166	0.9402643690204421	0.9917748408397812	0.9539889769175615	0.9967043287141466	23.08903545428604	-1.4221506588252777	GTF2IRD1;GTF2I
KEGG_2019_Human	Focal adhesion	5/199	0.6232187234997424	0.9917748408397812	0.6895540440898701	0.9967043287141466	3.0569707174862057	-1.4455122670101723	COMP;ERBB2;THBS2;PAK2;VAV1
KEGG_2019_Human	Metabolism of xenobiotics by cytochrome P450	1/74	0.8675574320969638	0.9917748408397812	0.8848028394537596	0.9967043287141466	10.980082316208767	-1.5599794409209429	CYP2S1
KEGG_2019_Human	Staphylococcus aureus infection	1/68	0.8439234761959455	0.9917748408397812	0.8629572216461245	0.9967043287141466	9.723414349842725	-1.6499997901140089	ICAM1
KEGG_2019_Human	Phospholipase D signaling pathway	1/148	0.9825922181020446	0.9917748408397812	0.9866169192833618	0.9967043287141466	96.37970924624584	-1.6925316861136397	DNM2
KEGG_2019_Human	T cell receptor signaling pathway	2/101	0.7593530926999197	0.9917748408397812	0.7935820776661211	0.9967043287141466	7.073871141356449	-1.9473546823788117	PAK2;VAV1
KEGG_2019_Human	Oocyte meiosis	1/125	0.967265004465014	0.9917748408397812	0.9738133821977901	0.9967043287141466	62.63176996205429	-2.0845589836422183	CCNE1
KEGG_2019_Human	Cellular senescence	5/160	0.4313475650788816	0.9917748408397812	0.5019153546355113	0.9967043287141466	2.479411493331314	-2.084791083340152	CDKN2A;CCNE1;NBN;SQSTM1;TP53
KEGG_2019_Human	Systemic lupus erythematosus	2/133	0.8764318582025532	0.9917748408397812	0.8993597341001648	0.9967043287141466	16.68855260835983	-2.2011586870030557	CD40;SSB
KEGG_2019_Human	Cushing syndrome	4/155	0.6027473968050936	0.9917748408397812	0.6630516276940284	0.9967043287141466	4.398272235095669	-2.2266564622749416	NCEH1;CDKN2A;CCNE1;WNT7A
KEGG_2019_Human	Thermogenesis	7/231	0.4286470169362889	0.9917748408397812	0.5124214921447021	0.9967043287141466	2.865627612127561	-2.42753477007519	SMARCE1;SMARCD1;SMARCC1;SMARCB1;ACTL6A;ARID1A;SMARCA4
KEGG_2019_Human	Pancreatic secretion	1/98	0.9313611851881387	0.9917748408397812	0.9425611166653364	0.9967043287141466	35.919913179492134	-2.554197601807732	CD38
KEGG_2019_Human	Chemokine signaling pathway	6/190	0.4038349696713093	0.9917748408397812	0.48058713481488535	0.9967043287141466	3.043686203435658	-2.7598593463700927	HCK;STAT1;STAT2;STAT3;DOCK2;VAV1
KEGG_2019_Human	Tuberculosis	3/179	0.8636438910635299	0.9917748408397812	0.893259221689947	0.9967043287141466	21.054269727503094	-3.0864455810770286	STAT1;EP300;RAB7A
KEGG_2019_Human	Retinol metabolism	1/67	0.8395940526407333	0.9917748408397812	0.8589348902806968	0.9967043287141466	20.85171075595713	-3.6456458539531953	CYP2S1
KEGG_2019_Human	Toll-like receptor signaling pathway	2/104	0.7734697071885691	0.9917748408397812	0.8066142878266603	0.9967043287141466	15.736156586559137	-4.0421272346677615	CD40;STAT1
KEGG_2019_Human	Human immunodeficiency virus 1 infection	2/212	0.979286122722622	0.9917748408397812	0.9853008992262449	0.9967043287141466	197.49506436782798	-4.133851935758451	PAK2;BCL2L1
KEGG_2019_Human	cAMP signaling pathway	2/212	0.979286122722622	0.9917748408397812	0.9853008992262449	0.9967043287141466	216.41287026150292	-4.529828456813272	EP300;VAV1
KEGG_2019_Human	Viral carcinogenesis	8/201	0.17554834624503524	0.8025067256915894	0.23940193640451557	0.9967043287141466	2.8006870861536366	-4.872749651654559	CDKN2A;CCNE1;STAT3;EP300;EIF2AK2;CHD4;TP53;GTF2E2
KEGG_2019_Human	TNF signaling pathway	2/110	0.799546399462563	0.9917748408397812	0.8305080193684697	0.9967043287141466	22.075554393797326	-4.938538008707766	VCAM1;ICAM1
KEGG_2019_Human	Cytokine-cytokine receptor interaction	3/294	0.9866093468770746	0.9917748408397812	0.9915131603354271	0.9967043287141466	368.0536180861622	-4.961773667239122	CD40;TNFSF10;INHBA
KEGG_2019_Human	Transcriptional misregulation in cancer	7/186	0.2355950375953616	0.9042021120241135	0.3048024603268343	0.9967043287141466	3.5631249040258184	-5.150999058379687	SS18;CD40;PAX8;CCNT1;ASPSCR1;TP53;BCL2L1
KEGG_2019_Human	Tight junction	5/170	0.48360762137288227	0.9917748408397812	0.5545169461886905	0.9967043287141466	8.166382978056747	-5.932725344575647	PRKCI;ERBB2;SYMPK;ARHGEF2;YBX3
KEGG_2019_Human	Purine metabolism	3/129	0.678225426725921	0.9917748408397812	0.7264497471212396	0.9967043287141466	24.17073075096953	-9.384903981860246	IMPDH2;GMPS;GART
KEGG_2019_Human	Ras signaling pathway	3/232	0.9510250435916214	0.9917748408397812	0.96508575439517	0.9967043287141466	215.6421457492688	-10.828445081586928	RASAL1;PAK2;BCL2L1
KEGG_2019_Human	NOD-like receptor signaling pathway	7/178	0.20444361596527333	0.8533298753333148	0.26907654902851263	0.9967043287141466	7.103964194562643	-11.277280724701063	GBP5;DHX33;STAT1;STAT2;CASP1;GBP1;BCL2L1
KEGG_2019_Human	Osteoclast differentiation	3/127	0.667951114695889	0.9917748408397812	0.7168151132269719	0.9967043287141466	28.90890127842053	-11.6659063972759	STAT1;STAT2;SQSTM1
KEGG_2019_Human	Herpes simplex virus 1 infection	7/492	0.9798768741905128	0.9917748408397812	0.9895068338049359	0.9967043287141466	623.0229416791857	-12.66503077887272	NXF1;STAT1;STAT2;NXF2B;EIF2AK2;TP53;BCL2L1
KEGG_2019_Human	Platelet activation	3/124	0.6520947641424916	0.9917748408397812	0.7018769738240972	0.9967043287141466	30.92471685603673	-13.222338432695905	PRKCI;ARHGEF1;FERMT3
KEGG_2019_Human	Natural killer cell mediated cytotoxicity	3/131	0.6882627816954002	0.9917748408397812	0.7358275960744338	0.9967043287141466	46.48174460217635	-17.364862283471414	TNFSF10;VAV1;ICAM1
KEGG_2019_Human	Endocytosis	4/244	0.8970863672079811	0.9917748408397812	0.9249439772432507	0.9967043287141466	194.97934582120376	-21.175368615281158	PRKCI;CHMP5;DNM2;RAB7A
KEGG_2019_Human	Phagosome	5/152	0.3887780109455239	0.9917748408397812	0.458221648627686	0.9967043287141466	25.526402598520164	-24.115986256753388	COMP;TUBB2B;THBS2;TUBB4A;RAB7A
KEGG_2019_Human	Human cytomegalovirus infection	4/225	0.8584998922377727	0.9917748408397812	0.8932571072890113	0.9967043287141466	168.07388407624362	-25.64281805955133	CDKN2A;STAT3;ARHGEF1;TP53
KEGG_2019_Human	Proteoglycans in cancer	6/201	0.4563503944301848	0.9917748408397812	0.5341411909134626	0.9967043287141466	37.006318475437936	-29.031247969386005	STAT3;ERBB2;WNT7A;ARHGEF1;TP53;EIF4B
KEGG_2019_Human	Regulation of actin cytoskeleton	5/214	0.6858721519002909	0.9917748408397812	0.7474947537237534	0.9967043287141466	125.11154345257174	-47.175063539068915	DIAPH3;ARHGEF1;WASF1;PAK2;VAV1
KEGG_2019_Human	Human T-cell leukemia virus 1 infection	8/219	0.2382498434127949	0.9042021120241135	0.31273271332784824	0.9967043287141466	37.88497309541975	-54.343546296953534	CD40;XPO1;CDKN2A;CCNE1;EP300;TP53;BCL2L1;ICAM1
KEGG_2019_Human	MAPK signaling pathway	6/295	0.8085627049520225	0.9917748408397812	0.8598537082468455	0.9967043287141466	260.0320116040014	-55.256034286306715	MAPKAPK3;ERBB2;PAK2;MAPK8IP3;TP53;MAP4K3
KEGG_2019_Human	MicroRNAs in cancer	8/299	0.5560950287276935	0.9917748408397812	0.6443919733223142	0.9967043287141466	166.01320596212074	-97.41921947440814	CDKN2A;CCNE1;STAT3;ERBB2;DNMT3A;IGF2BP1;EP300;TP53
KEGG_2019_Human	PI3K-Akt signaling pathway	11/354	0.35607638842166417	0.9917748408397812	0.458272701863171	0.9967043287141466	105.21428571428572	-108.64532324838952	COMP;CCNE1;CDC37;ERBB2;THEM4;PIK3AP1;PCK1;THBS2;TP53;EIF4B;BCL2L1
KEGG_2019_Human	Human papillomavirus infection	11/330	0.2765855652477598	0.9042021120241135	0.3703914704231944	0.9967043287141466	126.93405268620113	-163.14009323244392	COMP;PRKCI;STAT1;CCNE1;STAT2;WNT7A;EP300;EIF2AK2;CHD4;THBS2;TP53
KEGG_2019_Human	Pathways in cancer	17/530	0.26240897239453514	0.9042021120241135	0.37830103826566164	0.9967043287141466	174.1060508634042	-232.92795928881287	STAT1;CDKN2A;STAT2;STAT3;WNT7A;KEAP1;CKS1B;MSH6;PAX8;MSH2;CCNE1;ERBB2;CCDC6;EP300;ARHGEF1;TP53;BCL2L1
